EVNIN LUKE sold 22.5% of their position (139.80K shares) of WEREWOLF THERAPEUTICS, INC. on the open market
Open‑market sale worth $63.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/3/2026ACC: 0001134657-26-000016
Director10% Owner
Since Apr 2021
-139.80K
Net shares
Net seller
$63.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
139.80K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−80.46K
Price / share
$0.47
Trade value
$37.82K
% of position
12.9%
6/1/2026
622.58K→542.12K
Common Stock
Indirect
Shares
−29.59K
Price / share
$0.45
Trade value
$13.32K
% of position
5.5%
6/2/2026
542.12K→512.52K
Common Stock
Indirect
Shares
−29.75K
Price / share
$0.42
Trade value
$12.49K
% of position
5.8%
6/3/2026
512.52K→482.78K
Total
Net shares
−139.80K
Net value
-$63.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/1/2026 | S · Sale | −80.46K | $0.47 | $37.82K | 12.9% | 622.58K | 542.12K |
| Common Stock Indirect | 6/2/2026 | S · Sale | −29.59K | $0.45 | $13.32K | 5.5% | 542.12K | 512.52K |
| Common Stock Indirect | 6/3/2026 | S · Sale | −29.75K | $0.42 | $12.49K | 5.8% | 512.52K | 482.78K |
| Total | −139.80K | -$63.63K | ||||||
Derivative Transactions0
No derivative transactions reported